-
successes and proposes intelligent sensing and control solutions for automated robotic systems capable to be tele-operated using smart human-machine interfaces. This is an exciting PhD project that has a
-
encapsulate and embed these molecules into well-defined, injectable microparticles. This is one example of next-generation therapeutics, with a sustained and controlled drug release over a prolonged period
-
trade-offs between efficiency, cost, and emission control. To fully realise ammonia’s potential as a clean energy carrier, a fundamental rethinking of the combustion process is needed. This PhD project
-
simply know almost nothing about it! However, Team Booth recently discovered that Ki67, the famous cancer proliferation marker, controls the MCP, revealing novel functions in cell division fidelity
-
respond over time (e.g. changing shape), controlled by the arrangement of differential materials within them. The goal of this project will be to develop responsive 4D-printed biomaterial devices for drug
-
-controlled structural colours that respond to stimuli. You will develop the materials, methods, and designs necessary to 3D-print the next generation of structural colour devices, integrating optically- and
-
workspaces under positional restrictions. Develop smart control algorithms that will allow the robotics end-effectors to communicate with the central control system and coordinate tasks with other end
-
. This project will build upon our research and industrial successes, focusing on developing control solutions for automated robotic systems that can be teleoperated using intuitive human-machine interfaces
-
, control, and manufacturing problems in real-world applications. We are seeking talented candidates with: •First or upper second-class degree in mechanical, mechatronics, robotics, cybernetics or related